Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy

This study has been completed.
Sponsor:
Collaborator:
Virginia Mason Medical Center, Departments of Urology and Anesthesiology
Information provided by:
Benaroya Research Institute
ClinicalTrials.gov Identifier:
NCT00863928
First received: March 17, 2009
Last updated: May 25, 2010
Last verified: May 2010
  Purpose

This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study. 50% of patients will receive the suppository, 50% of patients will not. Neither you or your surgeon will know which group you are in.


Condition Intervention
Pain Management
Drug: Belladonna and Opium Suppositories

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy

Resource links provided by NLM:


Further study details as provided by Benaroya Research Institute:

Intervention Details:
    Drug: Belladonna and Opium Suppositories
    Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients scheduled for laparoscopic radical prostatectomy at Virginia Mason, who do not have chronic pain or allergies to opioid analgesics are eligible for this study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00863928

Locations
United States, Washington
Virginia Mason Medical Center
Seattle, Washington, United States, 98101
Sponsors and Collaborators
Benaroya Research Institute
Virginia Mason Medical Center, Departments of Urology and Anesthesiology
  More Information

No publications provided

Responsible Party: John Corman, Virginia Mason Medical Center
ClinicalTrials.gov Identifier: NCT00863928     History of Changes
Other Study ID Numbers: IRB08100, 370
Study First Received: March 17, 2009
Last Updated: May 25, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Signs and Symptoms
Opium
Antidiarrheals
Gastrointestinal Agents
Therapeutic Uses
Pharmacologic Actions
Antitussive Agents
Central Nervous System Agents
Respiratory System Agents
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Analgesics, Opioid

ClinicalTrials.gov processed this record on July 29, 2014